coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Altrincham Healthcare Alliance PCN, Trafford (LAD) · Health Inequalities Profile

    PCN U95344 · NHS Greater Manchester Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    47,655

    Registered population

    58.9% aged 18–64

    19.5%

    Aged 65+

    ICB 14.9% · England 17.9%

    0.8%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~292

    Core20 residents (est.)

    Resident basis; registered basis ~304 · see page 3

    6,775

    Hypertension register

    +8.80% in 3 yrs · England +5.60%

    387

    SMI register

    14.5% of Trafford (LAD)'s

    649

    COPD register

    Reviews -6.96% in 3 yrs

    Forecast to 2030

    7,940

    Hypertension patients, 2030

    +1,165 on today

    79.3%

    QRISK ≥20% on statins, 2030

    +6.95pp over 3 yrs

    5.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    64.5%
    Under-80 blood pressure control trails recent monitoring.

    Although 91.0% have a recent reading, under-80 control is 64.5% (England 67.8%), falling 3.5% over 2023 to 2025 (England +3.2%), which may reflect escalation.

    59.1%
    Asthma annual reviews sit below all benchmarks.

    Annual asthma reviews reach 59.1% against 63.7% in Trafford (LAD), 66.2% in the ICB and 65.7% in England, leaving a scale indicator of 1,199.

    79.9%
    Breast screening coverage leads borough and England.

    Breast screening coverage reaches 79.9% against 73.1% in Trafford (LAD), 68.8% in the ICB and 69.9% in England, rising +21.1% over 2023 to 2024.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older adults comprise 19.5% of registered patients, exceeding borough, ICB and national benchmarks

    Altrincham Healthcare Alliance PCN covers 47,655 registered patients across five practices. Patients aged 65+ represent 19.5% of the list (9,280), above Trafford (LAD) at 17.1%, NHS Greater Manchester Integrated Care Board at 14.9%, and England at 17.9%. Children aged 0–17 represent 21.6% (10,313; England 19.6%), and working-age adults (18–64) comprise 58.9% (28,062). Census resident data show 0.0% Gypsy or Irish Traveller and 0.1% Roma residents. Registered learning disability prevalence is 0.3% (160 patients; England 0.6%), which may reflect coding differences testable by register validation.

    Age profile

    0–1721.6%
    18–6458.9%
    65+19.5%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Trafford (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Trafford LA)2,0872,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.9%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)64.8%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Trafford LA)9501,0219552024/25
    Falls deaths, all ages, per 100,000 (Trafford LA)22.718.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 0.8% overall but concentrated entirely within Park Medical Practice

    ALTRINCHAM HEALTHCARE ALLIANCE PCN has an average IMD decile of 8.7 (Trafford: 7.0 decile; England: 5.5 decile; NHS Greater Manchester Integrated Care Board: 4.5 decile) and a Core20 share of 0.8% (Trafford: 8.2%; England: 21.0%; NHS Greater Manchester Integrated Care Board: 40.7%). A reconciliation check shows weighted practice Core20 share is 0.64% versus 0.78% PCN-wide (a 0.14 percentage point difference), alongside 292 estimated Core20 residents. Park Medical Practice records 3.9% (304 estimated patients), while the other four practices each record 0.0%.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Park Medical3.9% · 304 patients
    Altrincham0.0% · 0 patients
    Shay Lane0.0% · 0 patients
    West Timperley0.0% · 0 patients
    St Johns0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    387

    SMI register

    0.80% recorded prevalence

    160

    Learning disability register

    0.33% recorded prevalence

    19

    Care homes, 809 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Trafford (LAD), Census 2021

    The PCN records 387 patients on the severe mental illness register (0.8%; England 1.0%), alongside 19 catchment care homes with 809 beds. In wider borough data, Trafford (LAD) recorded an 8.7% unpaid care rate (ranking 34 of 39 North West local authorities) and 8 rough sleepers in the autumn 2025 snapshot; these local authority measures do not describe GP registered lists.

    Severe mental illness: physical health checks

    Recorded severe mental illness prevalence is 0.8% (Trafford (LAD) 1.1%, England 1.0%). Published checks show 86.8% had blood pressure recorded, 86.8% BMI, and 85.9% alcohol status. Unrecorded components could reflect incomplete annual health checks, testable by audit.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,775

    Hypertension register

    +8.80%

    Register growth, 3 yrs

    Trafford (LAD) +4.39% · England +5.60%

    −2.35pp

    BP control, under 80

    ≤140/90 · +1.95pp aged 80+

    +1,165

    More patients by 2030

    Forecast 7,940 (16.49%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 13.9% (6,775 patients), below Trafford (LAD) (15.1%), NHS Greater Manchester Integrated Care Board (14.4%) and England (15.2%). While 91.0% of patients have a recent blood pressure check (Trafford (LAD) 90.4%, England 90.0%), blood pressure control among patients under 80 is 64.5%, trailing Trafford (LAD) (66.5%), NHS Greater Manchester Integrated Care Board (68.6%) and England (67.8%). Furthermore, control in this under-80 group fell 3.5% over 2023 to 2025, whereas England rose +3.2%. Under-80 blood pressure control is lower than comparators and falling, which could reflect follow-up or treatment escalation gaps, testable by recall audit.

    Lipids and statins

    For patients with QRISK ≥ 20%, 62.8% receive lipid-lowering therapy, below Trafford (LAD) (67.1%) and England (63.6%), despite three-year growth of +12.4% over 2023 to 2025 (England +6.2%). Statin therapy in diabetes with cardiovascular disease reaches 81.8% (England 84.4%). Lower statin coverage in high-risk cohorts could reflect recall gaps, testable by clinical review.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202674,650£2.30£1.94£1.86£171,695
    Cardiovascular (all), 2025103,373£3.57£3.15£3.33£369,042

    In 2026, the PCN prescribed 74,650 lipid-regulating drug items at £2.30 per item, compared with £1.98 in Trafford (LAD), £1.94 in NHS Greater Manchester Integrated Care Board, and £1.86 in England (£32,846 more than at England's unit cost). Differences in unit cost do not establish clinical inefficiency. Spend per item suggests an opportunity to review local lipid prescribing choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −0.25%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.50%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 6.4% (2,932 patients; England 6.6%), and COPD prevalence is 1.3% (649 patients; England 1.9%). Annual asthma reviews stand at 59.1% (Trafford (LAD) 63.7%, England 65.7%), leaving an estimated 1,199 patients unreviewed, while reviews fell 0.2% over 2023 to 2025 (England +4.4%). COPD reviews fell 7.0% over 2023 to 2025 (England +2.8%) to 71.5% (Trafford (LAD) 75.3%, England 76.4%). Lower review rates could reflect recall capacity gaps, unverified locally and testable by recall audit.

    Cancer register and children's immunisation

    Cancer prevalence is 4.7% (2,296 patients; England 3.8%). In Q1 2025/26 childhood immunisation, age-five MMR dose 2 reaches 95.6% (England 82.8%), exceeding the 95.0% target. However, 24-month MMR dose 1 is 88.8% (England 88.3%) and age-five 4-in-1 booster coverage is 87.7% (England 80.9%), both below the 95.0% target. Coverage below target highlights an opportunity to strengthen pre-school booster recall.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.8%

    England 91.0%

    6-in-1 complete primary course at 24 months91.6%

    England 92.2%

    MMR dose 1 at 24 months88.8%

    England 88.3%

    MMR dose 2 at age 595.6%

    England 82.8%

    4-in-1 pre-school booster at age 587.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    Across NHS Greater Manchester ICB in 2022, 55.6% of staged cancers (6,491 of 11,679) were diagnosed at stage 1 or 2, compared with 55.3% in England, against the 75.0% national ambition by 2028 (about 2,270 extra early-stage cases required annually across the ICB). Staging was known for 70.8% of registered cancers (11,679 of 16,492). For the PCN, breast screening coverage reached 79.9% (England 69.9%) and cervical screening was 74.9% (England 66.8%). These system-level figures reflect wider cancer registration rather than PCN performance. System-wide staging gaps highlight that maintaining high screening participation across member practices is essential to support earlier diagnosis.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional July 2026 data at Manchester University NHS Foundation Trust, the cancer 62-day referral to treatment standard was 72.8% (standard 85.0%), trailing Northern Care Alliance NHS Foundation Trust (78.6%), NHS Greater Manchester Integrated Care Board (75.7%) and Stockport NHS Foundation Trust (74.7%), but above England (71.2%). The trust met the 28-day faster diagnosis standard at 80.1% (standard 75.0%), while 14.7% waited 6+ weeks for computed tomography (England 9.9%). These provider figures reflect acute system performance rather than PCN delivery. Secondary care waits may delay pathways, making primary care safety-netting important.

    Pathways within standard (%)ManchesterNorthern Care AllianceStockportGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.0675.2083.2179.5379.32
    31-day treatment (96%)92.5494.5497.3996.4992.50
    62-day referral to treatment (85%)72.8578.6574.6775.7371.16
    Diagnostic waits over 6 weeks (%)ManchesterNorthern Care AllianceStockportEngland
    MRI11.685.091.4121.40
    CT14.664.102.939.92
    Echocardiography4.9131.4817.4628.48
    Colonoscopy4.5140.045.5330.83
    Gastroscopy29.3536.485.3129.02
    All 15 DM01 tests8.9815.7114.0823.14
    Community services activityTrafford residentsGreater Manchester ICB
    Care contacts41,705573,310
    Referrals7,44594,470
    Patients with a contact13,840183,535

    Community services (residents of Trafford), Jun 2026 (provisional). In provisional June 2026 Community Services Dataset records, adults aged 65 and over accounted for 51.3% of community service contacts among Trafford residents (21,375 of 41,705 contacts). This borough-level measure describes wider resident activity rather than PCN activity. This concentration highlights an opportunity to coordinate with local community nursing teams on cancer rehabilitation and supportive care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    Overall QOF achievement in 2025/26 ranges from 93.6% at St Johns Medical Centre to 99.7% at Altrincham Medical Practice (England 92.5%). However, vaccination and immunisation achievement varies by 49.2 pp, from 50.8% at West Timperley Medical Centre to 100.0% at Park Medical Practice (England 55.2%), showing variation across practices.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    St Johns1250.056.5%75.2%88.4%
    Shay Lane1050.055.1%81.4%87.1%
    Altrincham1240.063.2%71.3%82.9%
    Park Medical1183.957.0%71.5%82.9%
    West Timperley1110.038.3%75.9%71.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNTrafford (LAD)AssetPCNTrafford (LAD)
    Care homes (catchment)19 (809 beds)n/aSchools (catchment)58n/a
    Children's centres716Places of worship58119
    Libraries39Primary schools (LA maintained)1439
    Primary academies517Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    59.1% reviewed (England 65.7%, Trafford (LAD) 63.7%); 1,199 of 2,932 registered patients unreviewed. For discussion, practices could run a single-template recall audit and offer flexible review slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Heart failure register coding validation

    Recorded prevalence is 0.8% (374 patients on the 47,655 list) vs 1.1% in Trafford (LAD) and England (gap +147 to +149). For discussion, practices could search clinical records for uncoded heart failure diagnoses or relevant prescribing, starting at Park Medical Practice (3.9% Core20). Low cost, quick to run.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register validation (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI health check audit (p4)Severe mental illness: QOF prevalenceMHIS · From Harm to HopePCN
    Hypertension control audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall audit (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Heart failure register coding validation (p12)Heart failure register · Heart Failure: QOF prevalence · Registered population—PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15